Register | Forgot password?
Switch to Arabic
Sunday, November 8 - 2009

Smoking cessation drugs to have warnings

  • Middle East: Thursday, July 02 - 2009 at 11:20

The US Food and Drugs Administration (FDA) has ordered Pfizer Inc. and GlaxoSmithKline PLC to add strong 'black box' warnings on Pfizer's Chantix and Glaxo's Zyban, smoking cessation drugs to highlight a risk of serious mental health problems including changes in behavior, depressed mood, hostility, and suicidal thoughts. Pfizer has said it had added the warning to the prescribing instructions for its drug.

Also consider reading:

Disclaimer:

The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.

AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.

In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.